The potential tumor suppressor protein prohibitin can prevent cell proliferation and this required its binding to the Rb protein. Prohibitin could repress the transcriptional activity of E2F family members and this required a part of the marked box region of E2F. The sub-cellular localization of prohibitin has been variously attributed to the mitochondria as well as the inner cell membrane.
Introduction
The E2F family of transcription factors play a major role in regulating mammalian cell cycle progression and is capable of eliciting a wide array of biological functions including differentiation, transformation and apoptosis (Adams and Kaelin, 1996; Muller and Helin, 2000; Nevins, 1998) . The transcriptional activity of E2F itself is regulated at multiple levels by a variety of mechanisms, to eliminate inappropriate activation causing unintended biological consequences (Dyson, 1998; Martinez-Balbas et al., 2000) . Many cellular genes required for the progression of the S phase have E2F sites in their promoter, and E2F activity is required for their expression (Adams and Kaelin, 1995) . Activity of E2F is repressed by the interaction with the members of the Rb family of tumor suppressor proteins, and de-repression of E2F by inactivation of the Rb at the G1/S boundary facilitates S phase entry (Harbour and Dean, 2000b) . It has been shown that over-expression or microinjection of E2F1 can induce S phase entry in quiescent cells, showing its potent proliferative capacity (Adams and Kaelin, 1996; Johnson et al., 1993; Johnson and Schneider-Broussard, 1998) .
The Rb protein represses E2F activity mainly by recruiting the histone deacetylase HDAC1 (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) . HDAC1 has been shown to be involved in the Rb-mediated repression of many cellular promoters. It has been proposed that Rb might repress other promoters through other mechanisms, like recruitment of proteins such as CtBP, Ring1, DNMT1 and HP1 (Meloni et al., 1999) , preventing the formation of preinitiation complexes (Ross et al., 1999) , or disruption of the interaction of E2F with co-activators. Rb protein interacts with HDAC1 directly, and unlike many other transcriptional repressors, additional corepressors are not necessary (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998) . Chromatin remodeling proteins like Brg1/hBrm are also involved in the Rb-mediated regulation of the cell cycle: complexes of Rb with HDAC1 alone, or with HDAC1 and Brg1/hBrm regulate different stages of cell cycle (Zhang et al., 2000) .
We had observed that a potential tumor suppressor protein, prohibitin, could repress the activity of E2F family members (Wang et al., 1999a,b) . Prohibitin is growth suppressive, and its growth inhibitory function coincides with its ability to repress E2F activity. Rband prohibitin-mediated repression of E2F responds to different signaling pathways: molecules like adenovirus E1A and cyclin dependent kinases affect Rb and not prohibitin, while IgM stimulation of B cells releases prohibitin-mediated repression of E2F specifically (Wang et al., 1999b) . Similarly, Rb family members are inactivated upon camptothecin treatment while prohibitin levels are elevated and it remains functional (Fusaro et al., 2002) . Our earlier studies indicate that prohibitin targets the conserved marked-box region of E2Fs1 -5 whereas Rb targets the transcriptional activation region of E2Fs1 -3 (Wang et al., 1999b) . Here, we show that a subset of prohibitin molecules colocalize with Rb in the nucleus; further a part of the marked box region of E2F1 can sensitize other factors to prohibitin mediated repression. It appears that while prohibitin recruits HDAC1 to effect repression, corepressors like N-CoR are involved. Finally, we show that prohibitin mediated repression correlates with histone deacetylation of two endogenous promoters and this changes upon IgM stimulation.
Results

Prohibitin is present in the nucleus of cells and co-localizes with Rb
Centrifugation experiments on rat liver lysates and immunohistochemistry on human tumor sections and rat ovaries had suggested that a subset of prohibitin maybe localized in the mitochondria or the cell membrane (Ikonen et al., 1995; Thompson et al., 1999) . Similarly, prohibitin and related proteins have been reported to associate with the IgM receptor in rat B-calls (Terashima et al., 1994) . At the same time, it has been shown that a highly related protein, prohibitin-2 can repress transcription mediated by steroid receptors (Delage-Mourroux et al., 2000; Montano et al., 1999) . In addition, our experiments had shown that prohibitin binds to Rb and represses E2F-mediated transcription. Since these are nuclear functions, we decided to examine whether prohibitin is localized in the nucleus of human cell lines. A double immunofluorescence experiment was conducted on the human diploid fibroblast cell line HSF8 (Wang et al., 1998) ; Rb was detected with a rabbit polyclonal antibody and a FITC conjugated secondary antibody. Prohibitin was detected using a mouse monoclonal antibody and a secondary antibody coupled to Rhodamine. As shown in Figure 1 , most of the Rb is localized in the nucleus, though some of it could be detected in the cytoplasm as well. Discrete spots of intense Rb staining could be seen in the nucleus, as has been reported by other groups. Prohibitin appears to be ubiquitously distributed in the cell and a good amount of it is in the nucleus. Super-imposition of the two images show that prohibitin and Rb co-localize in the nucleus; some foci of intense Rb staining showed the presence of prohibitin as well.
It has been proposed that a putative hydrophobic membrane-docking region spanning residues 1 -15 is responsible for the mitochondrial localization of prohibitin (McClung et al., 1995) . Since we find a portion of prohibitin in the nucleus, we examined whether this domain played a role in repressing E2F activity. A transient transfection experiment showed that deletion of the amino-terminal 32 or 74 amino acids did not affect the ability of prohibitin to repress E2F1-mediated transcription (Figure 1b) . A colony formation assay was conducted to check whether While deletion of the putative membrane-docking domain at the amino-terminus has no effect on growth suppression, deletion of the Rb-binding (74 -116) or E2F1 binding (185 -214) impairs growth suppression deletion of the amino-terminal residues affected the ability of prohibitin to inhibit cell proliferation. As shown in Figure 1c , transfection of a pSVNeo vector into T47D cells gave rise to approximately 200 neomycin resistant colonies after 2 weeks. Transfection of full length prohibitin reduced the number of colonies to around 55, indicating growth suppression. Interestingly, over-expression of prohibitin constructs lacking either 32 or 74 amino-terminal residues suppressed cell proliferation to a comparable extent; but as we had demonstrated earlier, the Rb and E2F binding regions of prohibitin (residues 74 -116 and 185 -214 respectively) are necessary for growth suppression. It thus appears that the amino-terminal domain of prohibitin is not needed for arresting cell proliferation. Since the nuclear functions of prohibitin appear to be involved in growth suppression, attempts were made to study the underlying molecular mechanisms further.
Marked box of E2F1 confers sensitivity to prohibitin-mediated repression Our earlier studies had shown that while a GAL4 -VP16 fusion protein cannot be repressed by prohibitin, constructs carrying different regions of E2F1 could be repressed by prohibitin. Thus GAL4 -E2F1 (283 -437) and E2F1 (1 -357) -VP16 fusion proteins could be repressed by prohibitin, suggesting that prohibitin targets the region 283 -357 shared between the two constructs (Wang et al., 1999b) . Supporting this hypothesis, prohibitin could not inhibit the transcriptional activity of an E2F1 molecule that lacked the region 304 -357 in transient transfection experiments. Experiments were designed to examine whether this region of E2F1 could render other transcription factors sensitive to prohibitin-mediated repression. As a first step, we generated chimeras of E2F1 with GAL4 DNA binding domain and tested their ability to respond to prohibitin and Rb. These chimeras had the varying lengths of the E2F1 marked box and the entire transcriptional activation domain of E2F1 fused to the GAL4 DNA-binding domain. As shown in Figure  2a , prohibitin could repress a fusion of GAL4 with E2F1 (283 -437) and E2F1 (304 -437), but could not affect a fusion carrying E2F1 (329 -437). This suggested that prohibitin could repress GAL4 -E2F1 mediated transcription only when residues 303 -357 of E2F1 was present. In contrast, Rb was able to repress all the GAL4 -E2F1 fusions, since they all had the transcriptional activation domain.
Complimentary studies were conducted on fusions of E2F1 with the VP16 activation domain; these constructs had the entire DNA-binding domain of E2F1 and varying lengths of the marked box region fused to VP16 transcriptional activation domain. Prohibitin could repress a fusion of E2F1(1 -357) or E2F1(89 -329) with VP16 activation domain ( Figure  2b ); but interestingly, prohibitin could not repress a construct carrying E2F1(89 -303) fused to VP16AD. Rb could not repress any of these constructs. This experiment suggests that prohibitin-mediated repression of these chimeras required the marked box region of E2F1 and was independent of the DNA binding and transcriptional activation domains.
Examined next was whether the region 304 -357 of E2F1 can render a transcription factor responsive to prohibitin mediated repression. As described earlier, transcription of a GAL4 -CAT reporter induced by a GAL4 -VP16 fusion protein cannot be repressed by prohibitin. We generated GAL4 -VP16 fusion proteins that had residues 263 -303 or 304 -357 of E2F1 fused to their carboxy-terminal; these two constructs stimulated the transcription from a GAL4 reporter efficiently, comparable to GAL4 -VP16 (Figure 2c ). Co-transfection of prohibitin did not repress GAL4 -VP16, or its fusion with residues 263 -303 of E2F1. In contrast, prohibitin was able to repress transcription of GAL4 -VP16 fused to the residues 304 -357 of E2F1. As expected, Rb could repress none of the above constructs since it specifically targets the transcriptional activation domain of E2F1. It appears that the region 304 -357 is sufficient for prohibitinmediated repression of E2F1, and this region of E2F1 can confer prohibitin response to other transcription factors.
Prohibitin recruits HDAC1 to repress transcription
It has been shown that Rb protein could repress transcription effectively when recruited to a promoter either through E2F1 or through fusion with GAL4 DNA binding domain (Adnane et al., 1995; Weintraub et al., 1992) . Since prohibitin is also a repressor of E2F activity, we examined whether prohibitin can also repress transcription when recruited to a promoter independent of E2F1. A fusion of prohibitin with the DNA binding domain of GAL4 was generated for this purpose. Two CAT reporters, driven by SV40 early or adenovirus major late promoters each carrying GAL4 DNA binding sites were transfected into T47D cells. Co-transfection of a GAL4 -VP16 construct could stimulate both the reporters above basal levels ( Figure  3a) . But co-transfection of a GAL4 -Rb construct or a GAL4 -prohibitin construct could lead to a marked repression of both the reporters. This was dependent on the two proteins being physically recruited to the promoter, since there was no repression when Rb and prohibitin were not fused to GAL4 (data not shown). This shows that prohibitin, like Rb, can repress transcription when recruited to a promoter, even independent of E2F1.
Since it had been shown that Rb recruits the histone deacetylase HDAC1 for transcriptional repression, we first examined whether it is involved in prohibitin mediated transcriptional repression as well (Luo et al., 1998) . First we examined whether the histone deacetylase inhibitor Trichostatin A can affect prohibitinmediated transcriptional repression. T47D cells were transfected with an E2CAT reporter whose activity was induced by E2F1 or E2F1 -VP16. Co-transfection of Rb or prohibitin could repress E2F1 mediated transcription ( Figure 3b) ; interestingly, treatment of the transfected cells with 200 nM TSA could reverse both Rb and prohibitin mediated repression. To rule out the possibility that TSA is functioning through endogenous Rb -HDAC1 complexes rather than prohibitin, a similar experiment was conducted where E2F1 -VP16 was used instead of E2F1. TSA could effectively reverse prohibitin-mediated repression of this construct as well; since Rb could not repress this construct, it may be concluded that TSA is affecting It has been reported that Rb interacts with HDAC1 directly independent of transcriptional co-repressors like N-CoR or Sin3A (Amann et al., 2001; Brehm et al., 1998; Luo et al., 1998; Lutterbach et al., 1998; Magnaghi-Jaulin et al., 1998) , and we made attempts to see whether it is true for prohibitin as well. Wholecell extracts were immunoprecipitated with antibodies to c-myc, N-CoR, Sin3A or HDAC1 and the presence of Rb in the precipitates was assessed by Western blotting (Figure 3c ). As reported earlier, there was no detectable amount of Rb associated with N-CoR, Sin3A or c-myc (which was the negative control). But a significant amount of Rb could be detected in association with HDAC1, confirming that Rb binds to HDAC1 directly. The blot was stripped and reprobed with an anti-prohibitin antibody, to check the presence of prohibitin. As can be seen from Figure 3c , there was a detectable amount of prohibitin associated with N-CoR, Sin3A as well as HDAC1, even when the immunoprecipitations were done under stringent conditions. This suggested that even though prohibitin recruits HDAC1, additional co-factors like N-CoR are involved.
The functional significance of the two interaction patterns was next examined by transient transfection experiments. The strategy was to test whether N-CoR and HDAC1 could synergize with Rb and prohibitin to repress transcription. T47D cells were transiently transfected with E2CAT and E2F1 to obtain a significant amount of transcription. Co-transfection of a minimal amount (0.2 mg) of prohibitin or Rb did not cause a significant reduction in the transcription (Figure 3d ). An increasing amount of N-CoR was cotransfected along with the low amounts of prohibitin; 0.25 mg of N-CoR had no effect, but 0.5 mg could reduce the levels of transcription by half. When 1 mg of N-CoR was co-transfected, there was a complete repression of E2F activity, suggesting that N-CoR can synergize with prohibitin to repress transcription. Similar results were obtained with HDAC1 as well, with 0.25 mg of HDAC1 having no effect on transcription and 1 mg effectively synergizing with 0.2 mg of prohibitin to bring about complete repression. 0.25 mg each of N-CoR and HDAC1 together could totally ablate transcriptional activity along with the low amount of prohibitin, suggesting that both these proteins are involved in prohibitin-mediated repression of E2F1. Even 2 mg each of N-CoR or HDAC1 did not inhibit E2F1 in the absence of prohibitin (data not shown), suggesting that these molecules have to be recruited to the promoter by other proteins to effect repression.
Similar experiments were conducted using minimal amount of Rb instead of prohibitin. While increasing amounts of N-CoR, up to 1 mg, could not synergize with Rb to repress E2F1, the lowest amount of HDAC1 tested (0.25 mg) could partially repress E2F1 and 0.5 mg could eliminate E2F activity completely. Co-transfection of low amounts of N-CoR did not enhance the ability of HDAC1 to synergize with Rb, indicating that N-CoR hardly contributes to the process. These results show that the functional effect of N-CoR and HDAC1 closely parallels their ability to associate with Rb and prohibitin physically: HDAC1 which binds to Rb can synergize with it, but N-CoR is unable to bind or synergize. But both the co-repressors can associate with prohibitin and synergize with it functionally.
Transcriptional repression by prohibitin coincides with histone deacetylation
Transcriptional activation normally follows acetylation of histones, mainly histones H3 and H4, while transcriptional repression correlates with histone deacetylation. Since prohibitin recruits HDAC1, it was next checked whether repression by prohibitin correlated with deacetylation of histones. Chromatin immunoprecipitation assays (CHIP assays) using antibodies to acetylated histone H3 (AcH3) were used for this purpose (Alberts et al., 1998; Dedon et al., 1991; Luo et al., 1998) . The first set of experiments was conducted on transiently transfected promoters. When E2CAT was transfected along with E2F1, CHIP assay could detect the association of the promoter with acetylated H3, correlating transcription with histone acetylation (Figure 4a ). Upon co-transfection of prohibitin to repress E2F1, there was no detectable amount of DNA present in the AcH3 immuneprecipitate, suggesting that the histones have been deacetylated. A CHIP assay was performed on a cFos CAT reporter as control; here, co-transfection of prohibitin did not repress c-Fos promoter, and there was still a considerable amount of DNA detectable in the AcH3 immunoprecipitate. This suggests that the recruitment of HDAC1 by prohibitin is a specific event that occurs only on promoters that are regulated by prohibitin.
To confirm whether the absence of DNA in the AcH3 immunoprecipitate was indeed due to deacetylation, E2CAT and E2F1 were co-transfected along with Rb or prohibitin; CHIP assays show the ablation of DNA in the IP (Figure 4b ). When the transfected cells were treated with 200 nM TSA, the transcriptional repression is relieved correlating with the appearance of DNA in the immunoprecipitate. Further, a mutant prohibitin which could not repress E2F activity did not bring about histone deacetylation. These results suggest that the absence of DNA in the AcH3 immunoprecipitate is due to the deacetylation of histones.
CHIP assays were designed to check whether prohibitin could bring about histone deacetylation when E2Fs lacking the marked box region was used. As shown in Figure 4c , DNA is associated with AcH3 when full length E2F1, or mutants lacking different regions of the marked box MutA (7283 -304), MutB (7304 -326) and MutC (7326 -357) or E2F1 -VP16 fusion is transfected. Upon co-transfection of prohibitin, DNA can be detected only when E2F1 304 -326 (MutB) and E2F1 326 -357 (MutC) are used. Since these E2F1 constructs are not repressed by prohibitin, there appears to be a direct correlation between the ability of prohibitin to repress transcription and to induce histone deacetylation. When Rb is used to repress the different E2F1 constructs, DNA can be detected only in the immunoprecipitate where E2F1 -VP16 is used, which is not repressed by Rb. This shows that both Rb and prohibitin bring about histone deacetylation, despite targeting different regions of E2F1.
Since stimulating IgM receptors in Ramos cells can reverse prohibitin-mediated repression of E2F1, attempts were made to examine whether this alters the acetylation status of histones. Ramos cells were transfected with E2CAT and E2F1, and DNA could be detected in association with acetylated histones. As in T47D cells, co-transfection of prohibitin repressed E2F activity, eliminating the DNA associated with acetylated histones (Figure 5a) . Stimulation of the transfected cells with an anti-IgM antibody led to a release of the repression along with the acetylation of histones as detected by the DNA present in the IP. Similarly, co-transfection of Rb also led to histone deacetylation, but treatment of the cells with an antiIgM antibody did not release the repression, and there was no increase in histone acetylation. This result shows that the recruitment of histone deacetylases by prohibitin is dependent on the functional status of prohibitin, and signals that can inactivate prohibitin also abrogate prohibitin-mediated histone deacetylation.
Attempts were made to evaluate whether the changes in histone acetylation were true for endogenous promoters as well. This was examined by performing CHIP assays on control Ramos cells or those stably over-expressing prohibitin. Two promoters, Cdc25A and Rb, which are regulated by E2F binding sites, were tested. Both the promoters were found to be associated with acetylated histones in the control Ramos cells but not in the Ramos cells over-expressing prohibitin (Figure 5b ). But upon IgM stimulation, there was DNA associated with AcH3, showing that histone deacetylases are no longer present on either promoter. No changes were observed on the endogenous c-Fos promoter, which is not regulated by prohibitin. Northern blot analysis show that the changes in the acetylation status of the promoters correlate with the expression of the message; both Cdc25A and Rb are expressed at very low levels in prohibitin overexpressing cells, but IgM treatment leads to transcription of both the genes (Figure 5c ). There was no significant change in the expression levels of a control GAPDH gene. The expression of these promoters 
Discussion
Regulation of transcription factor activity is effected at multiple levels -at the level of DNA binding, factor modification, interaction with other regulatory proteins, the recruitment of general transcription factors and the utilization of transcriptional coactivators and repressors. It has also become clear that the DNA template, especially the status of the nucleosomes and chromatin the promoter region, also contribute to the regulation (Collingwood et al., 1999; Howe et al., 1999; Luo and Dean, 1999; Xu and Rosenfeld, 1999) . Regulation of E2F activity by Rb and its family members involve all these processes at some level (Brehm and Kouzarides, 1999; Harbour and Dean, 2000b) . The results presented here show that the regulatory protein prohibitin represses E2F by utilizing histone deacetylases, but differ from Rb in that additional co-repressors are involved. In addition, our results show that a portion of total prohibitin is localized in the nucleus, and its membrane tethering domain is not necessary for its growth suppressive or transcription regulatory effects.
Though prohibitin was originally cloned based on its ability to suppress cell proliferation, its mechanism of action was not clear. The status of prohibitin gene/gene products in cancer is not clear either; studies have shown it to be a potential tumor suppressor, which is supported by the fact that it is a strong suppressor of cell proliferation. In contrast, it has been reported that prohibitin protein levels are elevated in human melanomas as well as testicular seminoma sections (Coates et al., 2001) . The same study suggests that prohibitin is localized to the mitochondria and responds to mitochondrial stress; but the immunofluorescence data presented in that study shows a significant amount of prohibitin in the nucleus, where its staining overlaps markedly with propidium iodide staining. The results presented in this paper shows that prohibitin is distributed in the nuclear and cytoplasmic compartments and the amino-terminal domain that supposedly localizes prohibitin to the mitochondria is not needed for its growth suppressive effects. Our previous studies had shown that the binding of prohibitin to Rb and E2F1 is necessary for its transcriptional repression and growth control. Prohibitin was found complexed with either Rb or E2F1 in different cell types including Ramos cells without overexpression of any component, as detected by immunoprecipitation -Western blot experiments (Wang et al., 1999a,b) . Because the Rb binding domain and the E2F binding domain on prohibitin are distinct (amino acids 74 -116 versus 184 -214, respectively), the three proteins could potentially associate together at the same time. Our results on a transcriptional regulatory role for prohibitin are further supported by the studies showing that a highly related protein, Phb2/BAP37/ REA mediates the repression of estrogen receptors (Delage-Mourroux et al., 2000; Montano et al., 1999) . Collectively, these observations suggest that while prohibitin might have other functions in the cell (Nijtmans et al., 2000 (Nijtmans et al., , 2002 Steglich et al., 1999) , its mitochondrial functions, if any, are distinct from its ability to bring about transcriptional repression or growth suppression.
We had found that prohibitin could repress the transcriptional activity of E2Fs1 -5, through the highly conserved marked box region. The studies presented here show that a sub-domain within this region is sufficient for prohibitin-mediated repression. Interestingly, this region of E2F1 can make unrelated factors like GAL4 and VP16 sensitive to prohibitin mediated repression. It seems possible that prohibitin interacts with these fusion proteins to recruit additional corepressors. Our results also show that prohibitin is capable of repressing transcription when recruited to a promoter by different means: either through binding to E2F, or when fused to a GAL4 DNA binding domain, as has been shown for Rb.
Recruitment of prohibitin to promoters leads to HDAC1-dependent transcriptional repression suggesting that the mode of repression is similar to one used by Rb. Involvement of N-CoR in the repression process, though, introduces an intriguing divergence in the precise molecular mechanism. Involvement of N-CoR in prohibitin-mediated, but not Rb-mediated repression, provides one additional node where signals can preferentially target prohibitin-regulated promoters. Sin3A, though found in association with prohibitin in the co-immunoprecipitation assay, did not functionally synergize with prohibitin or Rb. We had previously shown that certain signals like E1A and cyclin-dependent kinases cannot relieve prohibitinmediated repression of E2F. It is plausible that this is due to the involvement of a larger, high affinity repressor complex involving prohibitin. Various other co-repressors like DNMT1, CtIP/CtBP, HP1 and Ring1 (Dahiya et al., 2001; Meloni et al., 1999; Nielsen et al., 2001; Robertson et al., 2000) , as well as chromatin remodeling proteins like Brg/Brm are also involved in Rb-mediated repression of various cellular promoters (Harbour and Dean, 2000a) . It remains to be seen whether these co-repressors are involved in prohibitin-mediated transcriptional repression as well.
Stimulation of Ramos cells with an anti-IgM antibody was shown to preferentially rescue prohibitinmediated repression of E2F1 activity (Wang et al., 1999b) . We had observed that this coincides with a dissociation of prohibitin, but not Rb, from E2F1. Here we show that deacetylation of histones mediated by prohibitin is negated by IgM stimulation. This is most likely due to the dissociation of prohibitin and associated HDAC1 from E2F. Strikingly, IgM does not affect Rb-mediated repression of E2F1 and there is no alteration in the histone acetylation status in a transient transfection experiment. It is notable that IgM stimulation of control Ramos cells and those stably over-expressing prohibitin have different levels of histone acetylation on both the E2F-regulated promoters we examined. This correlated well with the expression of the two promoters as well. It appears that prohibitin represses the transcription of a variety of cellular genes and molecules that can modify histones facilitate this process.
It may be concluded that prohibitin is a potent inhibitor of E2F activity, and this inhibition can respond to specific extra-cellular signals. The actual mechanism of inhibition involves the action of histone deacetylases and co-repressors like N-CoR. The ability of prohibitin to target all the five transcriptionally active E2Fs might enable the cells to target a different set of genes than those regulated by Rb, since Rb can modulate the activity of only E2Fs1 -3. In addition, the ability of prohibitin to respond to molecules that cannot affect Rb facilitates the cells to respond to a wider array of signals to elicit the appropriate biological response. Prohibitin thus appears to constitute a different tier of regulation of E2F activity and cell proliferation.
Materials and methods
Cell lines
The human breast carcinoma cell line T47D and the human primary fibroblast HSF-8 cell line were maintained in DMEM media supplemented with 10% FBS. The human B cell lymphoma Ramos cell line was maintained in RPMI media supplemented with 10% FBS.
Chromosome immunoprecipitation (CHIP) assays
CHIP assays were conducted using published protocols (Luo et al., 1998) . Briefly, control or transfected cells were treated with formaldehyde (final concentration 1%) for 10 min at room temperature. Cells were washed with PBS and resuspended in lysis buffer (1% SDS, 10 mm EDTA, 50 mM Tris HCl, pH 8.1, 1 mM PMSF, 1 mM Pepstatin A, 1 mM aprotinin) and sonicated. The samples were centrifuged at 14K, 48C, for 5 min and the supernatant was divided into three; one-third was used to perform a control PCR for the total amount of plasmid transfected (or total amount of genomic DNA). Equal amount of the remaining DNA was immunoprecipitated with a control antibody or antibodies to AcH3 (UBI) in a buffer containing 0.01% SDS, 1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris HCl pH 8.1 and 150 mM NaCl. The antibody bound complexes were recovered on protein A beads and protein/DNA was eluted in 300 ml of elution buffer (1% SDS, 0.1 M NaHCO 3 ). Crosslinking was reversed by heating at 658C for 4 h. The DNA is resuspended in 200 ml of water, treated with 40 mg of proteinase K at 378C for 30 min, followed by phenol/ chloroform extraction and ethanol precipitation. PCR was done using 20 -100 ng (500 -1000 ng for genomic DNA) of DNA as template.
The following PCR primers were used for CAT gene, Rb promoter, Cdc25A promoter and cFos promoter. Transient and stable transfections T47D cells were transfected by calcium phosphate precipitation by using standard protocols (Wang et al., 1999b) . Ramos cells were transfected with pCDNA3-prohibitin by electroporation as described before. Individual clones stably expressing prohibitin were obtained by constant neomycin selection at 40 mg/ml, the resulting clones were confirmed by Western blotting. Ramos cells were treated with goat antihuman IgM antibody (Southern Biotechnology Associates, Inc.) at 1 mg/ml for 4 h before harvesting. Constructs pDCE2F1, pE2CAT, pSVRb, pCDNA3-prohibitin have been described before (Wang et al., 1999a; Zhang and Chellappan, 1995) . PCMX.N-CoR was a gift from Dr Scott W Hiebert, pBJ5-HDAC1-F is a kind gift from Dr Robin Luo and Dr Douglas Dean. pMLPGAL4-CAT, pCDNA3GAL4.Rb, pSVECGCAT were kind gifts from Dr Joseph Nevins. Deletion mutants of E2F1 were generated by PCR fused to GAL4DBD, VP16AD or GAL4VP16 by overlap extension PCR and cloned in pCR3.1 vector. GAL4-prohibitin was generated by a similar overlap-extension protocol. CAT assays were done using standard protocols (Sambrook et al., 1989) .
Stable transfections were performed on 35 mm dishes using approximately 10 000 cells and subjected to selection in the appropriate antibiotic for 14 days. The total amount of DNA transfected was equalized using salmon sperm DNA in every sample. Cells were fixed and stained with crystal violet and colonies having more than 20 cells were counted.
Immunofluorescence, immunoprecipitation and Western blot analysis
Double immunofluorescence experiments on human primary fibroblast HSF-8 cells were carried out using previously described protocols (Wang et al., 1998) and cells visualized by confocal microscopy using a Perkin Elmer Spinning Disc Confocal Imaging system mounted on a Nikon TE200 microscope. Anti-prohibitin mouse monoclonal antibodies were obtained from Neomarkers Inc., and anti-Rb rabbit polyclonal antibodies from Santa Cruz Biotechnologies. Whole cell extracts were immunoprecipitated with N-CoR, HDAC1 or Sin3A antibody (from Santa Cruz Biotechnology) using published protocols (Wang et al., 1998 (Wang et al., , 1999b . Western blot analysis using Rb monoclonal antibody (Calbiochem) and prohibitin antibody (from Neo Markers) was done using standard protocols and visualized by the ECL system (Amersham).
Northern blot analysis
Total RNA was prepared from Ramos cells followed by Northern blot analysis by using standard protocols (Fusaro et al., 2002) . Rb, Cdc25A and GAPDH probes were synthesized by using Prime-a-Gene Labeling System (Promega), and used to probe 10 mg of RNA. The bands were visualized by autoradiography.
